β-Amyloid-mediated vasoactivity and vascular endothelial damage
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Deposits of beta-amyloid are apparent in ageing and Alzheimer's disease, but the role of this peptide in neurodegeneration is unclear. The free-radical theory of ageing may also account for Alzheimer-type degeneration and consequently links between free-radical generation and beta-amyloid have been sought. We demonstrate here that beta-amyloid interacts with endothelial cells on blood vessels to produce and excess of superoxide radicals, with attendant alterations in endothelial structure and function. The superoxide radical can scavenge endothelium-derived relaxing factor and produce potent oxidizing agents, which can cause lipid peroxidation and other degenerative changes. The alterations in vascular tone and endothelial damage are prevented by the oxygen-radical-scavenging enzyme superoxide dismutase. These observations suggest a normal vasoactive role for beta-amyloid as well as a mechanism by which beta-amyloid may play a role in vascular abnormalities and neurodegeneration mediated by free radicals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“As shown by pharmacological studies, these high concentrations of A b may impair local BBB integrity (58-59), which in turn may contaminate brain ISF with blood and/or plasma that possesses A b -degrading activity (48)”
From Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier (2000) · cites this paper as [59]
In the citing paper
“Aβ4 constrict isolated cerebral and systemic blood vessels (Niwa et al., 2001; Paris et al., 2003; Thomas et al., 1996)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Thomas et al., 1996
Citations
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Lipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease
Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., & Rydel, R. E. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90009-b · Cited by 518
PGH synthase and lipoxygenase generate superoxide in the presence of NADH or NADPH.
Kukreja, R. C., Kontos, H. A., Hess, M. L., & Ellis, E. F. (1986) · Circulation Research · doi:10.1161/01.res.59.6.612 · Cited by 487
Bu�e, L., Hof, P. R., Bouras, C., Delacourte, A., Perl, D. P., Morrison, J. H., & Fillit, H. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294173 · Cited by 334
Scholz, W. (1938) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02890989 · Cited by 180
Soluble β-Amyloid Induction of Alzheimer's Phenotype for Human Fibroblast K + Channels
Etcheberrigaray, R., Ito, E., Kim, C. S., & Alkon, D. L. (1994) · Science · doi:10.1126/science.8146663 · Cited by 167
Untangling the pathophysio-chemistry of β-amyloid
Mattson, M. P. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1195-926 · Cited by 41
Research works printed but not linked: 2
- Davignon, J., Gregg, R. & Sing, C. Atherosclerosis 8, 1–21 (1988).
- Tomimoto, H., Nakimura, S., Wakita, H., Kimura, J. & Akiguchi, I. J. Cereb. Blood Flow Metab. 14, 563–573 (1994).
Cited by
Items 601–700 of 710
Jeong, H., Pan, Y., Akhter, F., Volkow, N. D., Zhu, D., & Du, C. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241304893 · Cited by 5
On the Molecular Correlations in the Pathobiochemistry of Alzheimer Disease
Stojanov, D. (2006) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2006.10817337 · Cited by 6
NONINFLAMMATORY DISORDERS OF THE ARTERIAL WALL
Caplan, L. R., & Bogousslavsky, J. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.061 · Cited by 5
a prospective case-cohort study
van Oijen, M., Albert Hofman, D., Breteler, M. M. B., Koudstaal, P. J., & Soares, H. D. (2006) · Cited by 5
Unexpected hydroxyl radical production in brewed tea under sunlight
Qin, L., Yang, L., Shiraiwa, M., Faiola, F., Zhong, H., Sonne, C., Yang, Y., Liu, S., Liu, G., Zheng, M., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgae015 · Cited by 5
“For example, free radical theory is considered the underlying mechanism of human aging and disease (48 – 50).”
BackgroundCognitive impairment, aphasia, and seizures in a 51-year-old man
Kern, R., Kreisel, S. H., Zoubaa, S., Szabo, K., Gass, A., & Hennerici, M. G. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70122-8 · Cited by 5
Structure and Pathology of the Blood–Brain Barrier
Nag, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30380-2_3 · Cited by 5
GIOKARINI, T., BONAFINI, L., Shearman, M. S., Hill, R. G., & Longmore, J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48507.x · Cited by 5
Vascular phenotype of amyloid precursor protein-deficient mice
d’Uscio, L. V., & Katušić, Z. S. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00539.2018 · Cited by 5
“Decreased superoxide anion levels in APP / mice aortas could also be related to the absence of amyloid- peptides, which are known to increase the production of superoxide anion (10, 11, 43).”
BackgroundWPËYW WYBRANYCH SKËADNIKÓWYWNOCI NA AKTYWNO PSYCHOFIZYCZNCZËOWIEKA
Leszczyńska, T., & Pisulewski, P. M. (2004) · Zywnosc-nauka Technologia Jakosc · Cited by 6
Zuliani, G., & Cervellati, C. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03217-y · Cited by 4
Xing, H., Kant, S., Kanuparthy, M., Harris, D. D., Stone, C., Broadwin, M., Zhang, Z., Pearson, E., Hu, J., Sauer, A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241309120 · Cited by 4
Xiang, B., Ding, N., Jiang, H., Liu, J., Yu, Y., Luan, J., Zhao, Y., Wang, Y., Yang, Y., Ji, C., et al. (2025) · Neurophotonics · doi:10.1117/1.nph.12.1.015013 · Cited by 5
“74 This corresponds with the slight decrease in VAD observed on day 14 post-injection.”
A role for estrogen in the primary prevention of Alzheimer's disease
Thomas, T. (2001) · Climacteric · doi:10.1080/713605083 · Cited by 4
Self-citationDesigning Novel Peptidic Inhibitors of Beta Amyloid Oligomerization
Roy, S. S. (2010) · Libraries and Cultural Resources (University of Calgary) · doi:10.5072/prism/17548 · Cited by 8
Compensatory retinal blood flow enhancement in cognitively normal ApoE ε4 carriers
Zhang, J., Cao, Q., Chen, W., Yang, S., Yang, S., Du, X., Wu, Y., Wu, X., Gu, W., Zhong, J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-16770-3 · Cited by 3
Greenberg, S. M. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511691836.005 · Cited by 3
Peripheral Markers of Alzheimer’s
Percy, M. E., Andrews, D. F., & Potter, H. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-005-6_9 · Cited by 4
Apolipoproteins in Different Amyloidoses
Sadowski, M., & Wısnıewskı, T. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_6 · Cited by 3
Salvolini, E., Vignini, A., Nanetti, L., Luzzi, S., Provinciali, L., Primio, R. D., & Mazzanti, L. (2013) · European Journal of Inflammation · doi:10.1177/1721727x1301100216 · Cited by 4
Neuroimaging of Cardiovascular Disease
Cohen, R. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6373-4_15 · Cited by 3
Elevated Blood Pressure and Alzheimer's Disease
Skoog, I. G. (1997) · Hospital Practice · doi:10.1080/21548331.1997.11443458 · Cited by 3
Xu, Q., Yang, J., Cheng, F., Ning, Z., Xi, C., & Sun, Z. (2023) · Brain Sciences · doi:10.3390/brainsci13121624 · Cited by 2
“Research has shown that the plasma A β may enhance endothelium-dependent vasoconstriction, leading to cerebral hypoperfusion [57,58], and conversely, cerebral hypoperfusion further promotes the excessive production and secretion of A β into circulation [59].”
BackgroundCAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome
Lahiri, D., Lima, B. S., Roncero, C., Verhoeff, N. P. L. G., Freedman, M., Al‐Shamaa, S., & Chertkow, H. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1422681 · Cited by 3
Vascular Dysfunction and Neurodegenerative Disease
Gao, Z., Cilento, E. M., Stewart, T., & Zhang, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-25249-6_1 · Cited by 2
The recognition of haemoglobin by antibodies raised for the immunoassay of β‐amyloid
Cutler, P., Brown, F., Camilleri, P., Carpenter, D., George, A. R., Gray, C. W., Haran, M., & Stewart, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00696-0 · Cited by 2
Weir, N. U., van Gijn, J., Lammie, G. A., Wardlaw, J. M., & Warlow, C. P. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.104 · Cited by 2
“19 20 Whereas the amyloidogenic protein in the Icelandic variant of hereditary cerebral amyloid angiopathy is cystatin C, 21 in all other forms of cerebral amyloid angiopathy, including sporadic and the Dutch familial variants, the protein is (cid:226) -amyloid, which is itself derived from…”
BackgroundKammermeier, B. (2000) · Wiley eBooks · doi:10.1002/14356007.a22_687 · Cited by 3
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Designing an Interactive Device to Slow Progression of Alzheimer’s Disease
Huang, T.-Y., Chen, H.-J., & Wu, F. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-22419-6_39 · Cited by 1
Utility of cerebrovascular imaging biomarkers to detect cerebral amyloidosis
Howe, M. D., Caruso, M. R., Manoochehri, M., Kunicki, Z. J., Emrani, S., Rudolph, J. L., Huey, E. D., Salloway, S., Oh, H., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14207 · Cited by 2
Treatment options for Alzheimer’s Disease: An overview of the amyloid, tau, and alternate hypotheses
Eroltu, K. (2023) · Journal of High School Science · doi:10.64336/001c.89250 · Cited by 1
Casey, N., & Faraco, G. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261448670 · Cited by 1
A whole-brain model of amyloid beta accumulation and cerebral hypoperfusion in Alzheimer’s disease
Corti, M., Ahern, A., Goriely, A., Kuhl, E., & Antonietti, P. F. (2026) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2026.119196 · Cited by 1
“Our model describes the coupling between A β and cerebral blood flow (CBF) associated with A β -induced vascoconstriction [48, 64, 47] and hypoperfusion-induced modulation of A β metabolism [59, 60, 62, 71].”
Cerebral Amyloid Angiopathy: Perspectives on Cerebrovascular Dysfunction
Johnson, A. (2013) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000e108 · Cited by 1
Course, L. L. (2009) · Syracuse University Libraries (Syracuse University) · Cited by 1
Potential Blood Biomarkers in Age-related Cerebral Small Vessel Disease
Cheng, X., & Dong, Q. (2012) · Current Translational Geriatrics and Experimental Gerontology Reports · doi:10.1007/s13670-012-0011-8 · Cited by 1
Tagluk, M. E., & Işık, İ. (2020) · DÜMF Mühendislik Dergisi · doi:10.24012/dumf.703270 · Cited by 1
Dietary Anti-Oxidants and the Risk for Brain Disease: The Hypothesis and Epidemiologic Evidence
Launer, L. J. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1067-3_13 · Cited by 1
Vasoactivity of Amyloid β Peptides
Paris, D., Town, T., & MULLAN, M. J. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_17 · Cited by 1
Self-citationKisler, K., Huuskonen, M. T., & Zloković, B. V. (2020) · Lab Animal · doi:10.1038/s41684-020-0556-7 · Cited by 1
XVIIIth International Symposium on Cerebral Blood Flow and Metabolism
(1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x9701701s01 · Cited by 1
Méthodologie et application de l'imagerie de la perfusion cérébrale et de la vasoréactivité par IRM
Villien, M. (2012) · theses.fr (ABES) · doi:10.70675/059baae2z25b0z4ad1z82d6ze189a440e9cc · Cited by 2
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins
Zloković, B. V., Ghiso, J. A., & Frangione, B. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_20 · Cited by 2
Switzer, A. R. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28634
Molecular Genetics and Molecular Biology of Alzheimer’s Disease
Sandbrink, R., & Beyreuther, K. T. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_72
The Role of Hypertensive Vascular Disease in Brain Aging and Neurodegeneration
Raji, C. A. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Coma, M. (2007) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Optimization of anti-Abeta antibody therapy
Karlnoski, R. (2007) · Digital Commons - University of South Florida (University of South Florida)
Cerebrovascular Disease in Diabetes Mellitus
Gray, C. S. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1008
Leandro, G. D. S. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-26092011-113731
Effects of A-beta immunotherapy and Omega-3 fatty acid administration in Alzheimer's transgenic mice
Jensen, M. (2006) · Digital Commons - University of South Florida (University of South Florida)
Cytotoxic properties of amyloidogenic L68Q cystatin C. A search for therapeutic agents
Ingólfsdóttir, I. E. (2013)
Genetic Determinants of Cognitive Function and Age-Related Brain Changes
Schuur, M. (2010) · RePub (Erasmus University Rotterdam) · Cited by 1
Alzheimer's disease and dementia with Lewy bodies: Special focus on the role of serpins
Nielsen, H. M. (2007) · Lund University Publications (Lund University)
Chapter 7 Cerebrovascular Disease
Penix, L. P., & Lanska, D. J. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60027-9
Arboix, A., Grau-Olivares, M., & Krupiński, J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9495-7_14
Long‐Term Venous Aβ1‐40 Infusion in Rats Causes Lung Hemorrhage and Brain Perivascular Gliosis
Su, G. C., Arendash, G. W., Kalaria, R. N., & MULLAN, M. J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48500.x
Self-citationEstablishing echocardiographic and arterial stiffness markers as predictors of cognitive decline
Mitu, F., Pădurariu, M., Joacăbine, C., Ciobica, A. S., & Chiriță, R. (2013) · Archives of Biological Sciences · doi:10.2298/abs1304299m
“Additionally, the specific BETAamyloid compound could be very closely related to the vascular endothelial cells producing free radicals and increasing oxidative stress (Thomas et al., 1996, Hanon et al., 2005).”
BackgroundMerlin, J. L. P. (2013) · Journal of the Chosun Natural Science · doi:10.13160/ricns.2013.6.3.125
Genetic and Vascular Risk Factors for Cognitive Decline and Cerebral Small-Vessel Disease
Reitz, C. (2006) · EUR Research Repository (Erasmus University Rotterdam)
Costa, D. A. (2005) · Digital Commons - University of South Florida (University of South Florida)
Evered, L. A., SILBERT, B. S., Scott, D. A., Maruff, P. T., Laughton, K. M., Volitakis, I., Cowie, T., Cherny, R. A., Masters, C. L., & Li, Q. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.07.012
Poon, H. F., Joshi, G., Sultana, R., Farr, S. A., Banks, W. A., Morley, J. E., Calabrese, V., & Butterfield, D. A. (2004)
Serpente, M. (2013) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/serpente-maria_phd2013-02-12
Kim, J. W., & Kwon, O. D. (2015) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2015.14.2.70
Consequences of Intracellular Amyloid in Vascular System
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00008-5
Fibrin Formation and Dissolution in the Progression of Amyloid-Beta Pathology in Alzheimer's Disease
Paul, J. (2009) · Digital Commons - RU (Rockefeller University) · doi:10.48496/m50g-qv97
Pathological Changes in the Elderly Human Brain
Mann, D. M. A. (1997) · Springer eBooks · doi:10.1007/978-1-4615-6001-2_2
Direct Evaluation of Alzheimer’s Disease-Specific Oxidative Stress with Multiphoton Microscopy
García-Alloza, M., Bacskai, B. J., & Dodwell, S. A. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch2
Cerebrovascular risk factors for dementia
Farkas, E. (2001)
Oxidative Stress in Down’s Syndrome
Ceballos-Picot, I. (1997) · Neuroscience intelligence unit · doi:10.1007/978-3-662-22516-5_6
Potential Protective Effects of Wine and the Wine-Derived Phenolic Compounds on Brain Function
Stockley, C. S. (2013) · CRC Press eBooks · doi:10.1201/b13736-21
Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases
Majerová, P., & Kováč, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_4
Abraham, A. (1999) · TSpace (University of Toronto)
ROLE OF PATHOGENIC PROTEINS AND CHRONIC INFLAMMATION IN THE OCCURRENCE OF ALZHEIMER'S DISEASE
Denysenko, A., Haikova, O. O., & Moskalenko, R. (2020) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2020;8(4):475-490
The role of NPxY domains in LRP1 receptor maturation and function
Pflanzner, T. (2011) · Gutenberg Open Science · doi:10.25358/openscience-3281
Cerebral amyloid angiopathy : new insights from transgenic mice
Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738
Koronare Herzerkrankung: Amyloid-beta – Option als Biomarker für die Kardiologie
Stellos, K. (2017) · Deutsches Ärzteblatt · doi:10.3238/perskardio.2017.03.31.05
Petrides, P. E. (1997) · Springer-Lehrbuch · doi:10.1007/978-3-662-06062-9_33
Petrides, P. E. (1998) · Springer-Lehrbuch · doi:10.1007/978-3-662-06060-5_33
Fathallah, S. S. (2023) · theses.fr (ABES) · doi:10.70675/cd31edacz7e53z4d37zaf55z5dfcf1f9ba3f
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24452535
Saiz-Vázquez, O. (2023) · Repositorio Institucional de la Universidad de Burgos (University of Burgos) · doi:10.36443/10259/9000
Pathogenic landscape shaped by cerebral amyloid oligomers
Huang, Y., Xu, M., Yuan, Z., & Ke, P. C. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00557
“For example, exposure of blood vessels to 10 μM Aβ for 15 minutes induced excessive superoxide radical production, leading to lipid peroxidation and structural damage to the endothelium (Thomas et al., 1996).”
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24452610
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26633139
Additional file 1 of Tau reduction in aged mice does not impact Microangiopathy
Bennett, R. E., Hu, M., Fernandes, A. R., Perez-Rando, M., Robbins, A., Kamath, T. V., Dujardin, S., & Hyman, B. T. (2020) · Figshare · doi:10.6084/m9.figshare.12825330
Liu, X., Halvorsen, S., Blanke, N., Downs, M. J., Stein, T. D., Bigio, I. J., Zaia, J., & Zhang, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26633136
Presa, J. (2024) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Ahmed, C. (2024) · IUScholarWorks (Indiana University) · doi:10.7912/psj7-4j53
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c · Cited by 1
Chouraki, V. A. (2013) · theses.fr (ABES) · doi:10.70675/3ad681e8z1330z4422zb068zfb803483ea12 · Cited by 2
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
Fanet, H. (2018) · theses.fr (ABES) · doi:10.70675/b46d2065zecc9z4e97zae20zf9e2e4fe0c69 · Cited by 1
Ke, Q., Tian, Y., Zeng, Y., Liu, Z., Cai, Z., Xiong, X., Wu, P., Huang, Y., Liu, X., & Wang, S. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c05459
Metadata
- Authors
- Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M.
- Affiliations
- University of South Florida (US)
- Venue
- Nature
- Published
- 1996-03
- Volume
- 380
- Issue
- 6570
- Pages
- 168-171
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1990427131
- Cited by
- 703
- References
- 12
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 18 · 2023: 22 · 2022: 9 · 2021: 15 · 2020: 24 · 2019: 19 · 2018: 5 · 2017: 12 · 2016: 22 · 2015: 26 · 2014: 16 · 2013: 26 · 2012: 13
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- amyloid-beta, Alzheimer's disease, vascular endothelial cells, superoxide, free radicals, superoxide dismutase, endothelium-derived relaxing factor, lipid peroxidation, vascular tone, neurodegeneration, aging, oxidative stress
- MeSH terms
- Acetylcholine, Alzheimer Disease, Animals, Aorta, Blood Vessels, Endothelium, Vascular, Nerve Degeneration, Phenylephrine, Superoxides, Vasoconstriction, Vasoconstrictor Agents, Vasodilator Agents, Amyloid beta-Peptides, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.